ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone
Showcasing at ASCRS 2025: More than 2 million cases planned with ZEISS VERACITY…
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR) today announced that GPCR Therapeutics…
Positron Corporation Secures Agreement to Sell Four PET-CT Scanners
Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron”…
NeuroOne OneRF Technology Success Story Featured on Fox News
Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10…
VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma
April 14, 2025 09:00 ET | Source: VIVUS LLC — Innovative ethanol-free…
AI-Driven 360 Patient Process Optimization and Specimen Management Solution with QIAM Integrated with Epic
Revolutionizing Healthcare with Quake Real-Time UHF RFID process optimization solution for Patients,…
Philips Applauded by Frost & Sullivan for Improving Imaging Quality and Efficiency in Healthcare with Its CT 3500 Imaging Solution
Philips CT 3500, a scalable, adaptable, and durable imaging solution, improves efficiency…
Healthcare Sector Faces Escalating Cybersecurity Risks Amid Digital Transformation
Advanced Security Solutions and Regulatory Compliance Key to Strengthening Resilience LONDON, March…
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption…
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today…